Darunavir Ethanolate/Ritonavir

乙醇达芦那韦/利托那韦

Report date: 2022/01/14 13:23:58

Base Information

Drug NameDarunavir Ethanolate/Ritonavir
Drug Alias NameRitonavir/Darunavir EthanolateDarunavir/RitonavirDarunavir Ethanolate and RitonavirVirontarVirontar N
ClassificationSmall molecules > Synthetic peptide
Mechanisms of ActionHuman immunodeficiency virus type 1 protease inhibitors
TargetsHuman immunodeficiency virus type 1 protease
Therapy Area/IndicationsHIV Infections
Global Approved IndicationsHIV Infections
Approved Indications in ChinaN/A
Original Approved Country/TerritoryArgentina
Original Approved Date2015/01/01
Country/TerritoryUgandaSenegalZimbabwe +[5] 
CombinationsYes Darunavir EthanolateRitonavir
Global Highest StatusApproved
Highest Status in ChinaN/A
Originator CompaniesLaboratorios Richmond
China Registration ClassN/A

Develop Information

Active CompaniesLaboratorios Richmond
Inactive CompaniesPenta Global Foundation Pte Ltd
Active IndicationsHIV Infections
Inactive IndicationsN/A

Other Information

ATC CodeJ05AR
Related LinksN/A